Basel Metropolitan Area
I am a proactive leader with 15 years of experience in commercial insights & analytics, strategic partnerships and digital health across global pharma and started my career in strategy consulting. I have a proven record leading cross-functional projects that are shaping the future of healthcare in ambiguous and rapidly changing environments. Recognized for bridging strategy and execution, I am passionate about innovative problem-solving and insights generation through inclusive leadership. I excel at finding a path forward by leveraging diverse perspectives and cross-functional collaboration while driving measurable impact. Transferable skills & capabilities: - Leading and structuring cross-functional (transformation) projects with a strong analytical mindset, detail orientation and a positive, inclusive attitude - Identifying and structuring the best path forward in a new, undefined and/or ambiguous situation that requires innovative problem-solving skills and strategic thinking (e.g. first biosimilars to our top 2 oncology brands, innovative public-private partnerships to shape the future of personalized healthcare) - Trusted collaboration partner and connector who can communicate effectively, provides constructive advice and leverages advanced co-active coaching skills - Ability to simplify and clarify complexity to align key stakeholders towards shared objectives - Getting up to speed quickly on new topics and new functional skills
• Acted as key enabler for early digital health concepts by working with global product teams to define business models and value propositions for patients, society and Roche as well as assessing healthcare system readiness. Enabled and maintained close collaboration with key geographical markets. • Led the establishment of a new operating model following a department restructuring incl. processes and resource allocation strategies • Spearheaded the implementation of a new planning process for the team (outcomes based planning)
• Developed the cross-functional PHC Ecosystem Collaboration Playbook capturing the key learnings from a set of pioneering collaborative partnerships with external health system stakeholders to drive adoption of personalized healthcare in key markets • Led one of these collaboration projects with external healthcare system stakeholders through contract finalization and the start of the implementation phase (Alliance Management). • Developed impact frameworks for these partnerships via 40+ stakeholder interviews (global and local) to qualitatively & quantitatively measure patient, health systems and operational outcomes.
• Established the CI function incl. regular reports on external events and implications to Roche as first phc CI Manager. • Led two full-day competitive simulation workshops to develop a deep understanding of biopharma & tech competitors and the implications of their personalized healthcare activities for Roche.
CMS Pharma is a specialist corporate strategy and M&A advisor. CMS Pharma is a brand of CMS Advisors, focused on the custom manufacturing industry (pharmaceuticals and life scinence products). Senior Consultant on a variety of projects such as assessment & design of corporate strategies and business plans as well as various market and benchmarking studies, M&A buy-side and sell-side support, financial analysis. Assisted in the design of customer proposals and other sales and marketing activities. Responsible for the hiring, supervision and management of interns.
Internship in the Strategy department of Lonza Exclusive Synthesis, reporting to the Vice President of Strategy and Special Projects. Involved in Strategic planning, process development & support, M&A valuation and on-going M&A support, competitor analysis and tracking as well as support in various strategic projects including pipeline deals and the development of business plans. Master Thesis (2010) in collaboration with the Marketing Intelligence department of Lonza Topic: Evaluation of the Indian Pharmaceutical Market - Discovering opportunities for Lonza by means of market research and a case study of three generations of dibenzazepines